ELN Stock Overview
EL.En. S.p.A. engages in the research and development, manufacture, distribution, and sale of laser systems in Europe and internationally.
No risks detected for ELN from our risk checks.
Price History & Performance
|Historical stock prices|
|Current Share Price||€14.08|
|52 Week High||€18.20|
|52 Week Low||€11.04|
|1 Month Change||3.68%|
|3 Month Change||13.92%|
|1 Year Change||14.66%|
|3 Year Change||223.86%|
|5 Year Change||130.16%|
|Change since IPO||854.98%|
Recent News & Updates
EL.En. S.p.A. (BIT:ELN) Shares Could Be 21% Below Their Intrinsic Value Estimate
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of EL.En. S.p.A...
EL.En (BIT:ELN) Is Experiencing Growth In Returns On Capital
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. In a perfect...
Here's Why We Think EL.En (BIT:ELN) Is Well Worth Watching
Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...
|ELN||IT Medical Equipment||IT Market|
Return vs Industry: ELN exceeded the Italian Medical Equipment industry which returned -22.9% over the past year.
Return vs Market: ELN exceeded the Italian Market which returned -16% over the past year.
|ELN Average Weekly Movement||4.4%|
|Medical Equipment Industry Average Movement||6.8%|
|Market Average Movement||4.9%|
|10% most volatile stocks in IT Market||7.7%|
|10% least volatile stocks in IT Market||3.1%|
Stable Share Price: ELN is not significantly more volatile than the rest of Italian stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: ELN's weekly volatility (4%) has been stable over the past year.
About the Company
EL.En. S.p.A. engages in the research and development, manufacture, distribution, and sale of laser systems in Europe and internationally. The company offers medical laser equipment for use in the fields of physiotherapy, orthopedics, traumatology, rheumatology, dermatology, sports and rehabilitative medicines, surgery, aesthetics, and art; and laser sources and systems for cutting, welding, marking, and engraving on countless materials.
EL.En Fundamentals Summary
|ELN fundamental statistics|
Is ELN overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|ELN income statement (TTM)|
|Cost of Revenue||€382.29m|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
Sep 12, 2022
|Earnings per share (EPS)||0.61|
|Net Profit Margin||8.15%|
How did ELN perform over the long term?See historical performance and comparison
1.4%Current Dividend Yield
Is ELN undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 5/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ELN?
Other financial metrics that can be useful for relative valuation.
|What is ELN's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does ELN's PE Ratio compare to its peers?
|ELN PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
GHC Garofalo Health Care
A048260 Osstem Implant
Price-To-Earnings vs Peers: ELN is good value based on its Price-To-Earnings Ratio (23x) compared to the peer average (26.3x).
Price to Earnings Ratio vs Industry
How does ELN's PE Ratio compare vs other companies in the European Medical Equipment Industry?
Price-To-Earnings vs Industry: ELN is good value based on its Price-To-Earnings Ratio (23x) compared to the European Medical Equipment industry average (29x)
Price to Earnings Ratio vs Fair Ratio
What is ELN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||23x|
|Fair PE Ratio||24.3x|
Price-To-Earnings vs Fair Ratio: ELN is good value based on its Price-To-Earnings Ratio (23x) compared to the estimated Fair Price-To-Earnings Ratio (24.3x).
Share Price vs Fair Value
What is the Fair Price of ELN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: ELN (€14.08) is trading below our estimate of fair value (€15.8)
Significantly Below Fair Value: ELN is trading below fair value, but not by a significant amount.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.
Discover undervalued companies
How is EL.En forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?
Future Growth Score3/6
Future Growth Score 3/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ELN's forecast earnings growth (9.7% per year) is above the savings rate (1.7%).
Earnings vs Market: ELN's earnings (9.7% per year) are forecast to grow faster than the Italian market (9.3% per year).
High Growth Earnings: ELN's earnings are forecast to grow, but not significantly.
Revenue vs Market: ELN's revenue (7.8% per year) is forecast to grow faster than the Italian market (0.01% per year).
High Growth Revenue: ELN's revenue (7.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ELN's Return on Equity is forecast to be low in 3 years time (18.6%).
Discover growth companies
How has EL.En performed over the past 5 years?
Past Performance Score6/6
Past Performance Score 6/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ELN has high quality earnings.
Growing Profit Margin: ELN's current net profit margins (8.2%) are higher than last year (6.6%).
Past Earnings Growth Analysis
Earnings Trend: ELN's earnings have grown by 19.6% per year over the past 5 years.
Accelerating Growth: ELN's earnings growth over the past year (64.9%) exceeds its 5-year average (19.6% per year).
Earnings vs Industry: ELN earnings growth over the past year (64.9%) exceeded the Medical Equipment industry 20.5%.
Return on Equity
High ROE: ELN's Return on Equity (61.3%) is considered outstanding.
Discover strong past performing companies
How is EL.En's financial position?
Financial Health Score5/6
Financial Health Score 5/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: ELN's short term assets (€152.5M) exceed its short term liabilities (€25.0M).
Long Term Liabilities: ELN's short term assets (€152.5M) exceed its long term liabilities (€41.7M).
Debt to Equity History and Analysis
Debt Level: ELN has more cash than its total debt.
Reducing Debt: ELN's debt to equity ratio has increased from 6.9% to 70.1% over the past 5 years.
Debt Coverage: ELN's debt is well covered by operating cash flow (132.1%).
Interest Coverage: ELN's interest payments on its debt are well covered by EBIT (189.6x coverage).
Discover healthy companies
What is EL.En current dividend yield, its reliability and sustainability?
Dividend Score 2/6
Cash Flow Coverage
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: ELN's dividend (1.42%) isn’t notable compared to the bottom 25% of dividend payers in the Italian market (1.65%).
High Dividend: ELN's dividend (1.42%) is low compared to the top 25% of dividend payers in the Italian market (5.18%).
Stability and Growth of Payments
Stable Dividend: ELN has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: ELN's dividend payments have increased, but the company has only paid a dividend for 9 years.
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (35%), ELN's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (25.2%), ELN's dividend payments are well covered by cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
EL.En has no CEO, or we have no data on them.
Experienced Board: ELN's board of directors are seasoned and experienced ( 21.6 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
EL.En. S.p.A.'s employee growth, exchange listings and data sources
- Name: EL.En. S.p.A.
- Ticker: ELN
- Exchange: BIT
- Founded: 1981
- Industry: Health Care Equipment
- Sector: Healthcare
- Implied Market Cap: €1.124b
- Shares outstanding: 79.82m
- Website: https://www.elengroup.com
Number of Employees
- EL.En. S.p.A.
- Via Baldanzese 17
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/08/14 00:00|
|End of Day Share Price||2022/08/12 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.